FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1666-1670 June 22, 1995 Number 25 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Silicone breast implants have been linked to a variety of illnesses, the most controversial of which are connective-tissue diseases and symptoms. To study this relation, we analyzed data from 14 years of follow-up of the Nurses' Health Study cohort.

Methods Women who were free from connective-tissue disease in June 1976 were followed through May 31, 1990, before there was widespread media coverage of the possible association of breast implants and connective-tissue diseases. Information was collected through biennial and supplementary mailed questionnaires and blinded reviews of medical records with the use of standardized criteria. Relative risk, the measure of association, was defined as the incidence rate of connective-tissue disease among women with breast implants divided by the corresponding incidence rate among women without breast implants.

Results Among 87,501 women who were eligible for follow-up, 516 were confirmed as having definite connective-tissue diseases and 1183 as having breast implants (of which 876 were silicone-gel–filled, 170 saline-filled, 67 double-lumen, 14 polyurethane-coated, and 56 of unknown type). The mean (±SD) period of follow-up after surgery was 9.9±6.4 years (range, 1 month to 40.5 years). Three of the patients with definite connective-tissue disease — all had rheumatoid arthritis — had implants (one silicone-gel–filled, one saline-filled, and one double-lumen). The age-adjusted relative risk of a definite connective-tissue disease among women with any type of implant was 0.6 (95 percent confidence interval, 0.2 to 2.0), as compared with women without implants. For women with silicone-gel–filled implants, the comparable relative risk was 0.3 (95 percent confidence interval, 0 to 1.9). The relative risk of self-reported signs or symptoms of connective-tissue disease for women with implants was 1.5 (95 percent confidence interval, 0.9 to 2.4); the risk of having any 1 of 41 signs, symptoms, or laboratory features of connective-tissue disease was 0.7 (95 percent confidence interval, 0.3 to 1.6).

Conclusions In a large cohort study, we did not find an association between silicone breast implants and connective-tissue diseases, defined according to a variety of standardized criteria, or signs and symptoms of these diseases.

Source Information

From the Departments of Rheumatology and Immunology (J.S.-G., E.W.K., M.H.L.) and Medicine (G.A.C., D.J.H., F.E.S., M.H.L.), Harvard Medical School; the Robert B. Brigham Multipurpose Arthritis and Musculoskeletal Diseases Center (J.S.-G., E.W.K., M.H.L.) and the Channing Laboratory (G.A.C., D.J.H., F.E.S.), Brigham and Women's Hospital; and the Department of Epidemiology, Harvard School of Public Health (G.A.C., D.J.H.) — all in Boston.

Address reprint requests to Dr. Liang at Brigham and Women's Hospital, Dept. of Rheumatology and Immunology, 75 Francis St., Boston, MA 02115.

Full Text of this Article

Related Letters:

Breast Implants and Connective-Tissue Diseases
Vasey F. B., Aziz N., Abraham J. L., van Vollenhoven R., Liang M. H., Karlson E. W., Sánchez-Guerrero J.
Extract | Full Text  
N Engl J Med 1995; 333:1423-1424, Nov 23, 1995. Correspondence

This article has been cited by other articles:

• Beier, J. P., Horch, R. E., Bach, A. D., Lee, M. J.R., Bishop, H. M., Fatah, F. T., Vasey, F. B., Ricca, L., Chargari, C., Kirova, Y. M., Fourquet, A., Cordeiro, P. G. (2009). Breast Reconstruction after Breast-Cancer Surgery. NEJM 360: 418-421 [Full Text]  
• Cordeiro, P. G. (2008). Breast Reconstruction after Surgery for Breast Cancer. NEJM 359: 1590-1601 [Full Text]  
• Alam, M., Danahey, D. G. (2005). Permanent Injectables for Soft Tissue Augmentation: Avoiding Misinformation and a Reprise of the Breast Implant Debacle. Arch Facial Plast Surg 7: 370-373 [Full Text]  
• Karlson, E W, Costenbader, K H, McAlindon, T E, Massarotti, E M, Fitzgerald, L M, Jajoo, R, Husni, E, Wright, E A, Pankey, H, Fraser, P A (2005). High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women. Lupus 14: 832-836 [Abstract]  
• Brinton, L. A., Buckley, L. M., Dvorkina, O., Lubin, J. H., Colton, T., Murray, M. C., Hoover, R. (2004). Risk of Connective Tissue Disorders among Breast Implant Patients. Am J Epidemiol 160: 619-627 [Abstract] [Full Text]  
• Gaubitz, M., Jackisch, C., Domschke, W., Heindel, W., Pfleiderer, B. (2002). Silicone breast implants: correlation between implant ruptures, magnetic resonance spectroscopically estimated silicone presence in the liver, antibody status and clinical symptoms. Rheumatology (Oxford) 41: 129-135 [Abstract] [Full Text]  
• Dush, D M (2001). Breast implants and illness: a model of psychological factors. Ann Rheum Dis 60: 653-657 [Abstract] [Full Text]  
• Kjoller, K., Friis, S., Mellemkjaer, L., McLaughlin, J. K., Winther, J. F., Lipworth, L., Blot, W. J., Fryzek, J., Olsen, J. H. (2001). Connective Tissue Disease and Other Rheumatic Conditions Following Cosmetic Breast Implantation in Denmark. Arch Intern Med 161: 973-979 [Abstract] [Full Text]  
• Naim, J. O., Satoh, M., Buehner, N. A., Ippolito, K. M. L., Yoshida, H., Nusz, D., Kurtelawicz, L., Cramer, S. F., Reeves, W. H. (2000). Induction of Hypergammaglobulinemia and Macrophage Activation by Silicone Gels and Oils in Female A.SW Mice. CVI 7: 366-370 [Abstract] [Full Text]  
• Janowsky, E. C., Kupper, L. L., Hulka, B. S. (2000). Meta-Analyses of the Relation between Silicone Breast Implants and the Risk of Connective-Tissue Diseases. NEJM 342: 781-790 [Abstract] [Full Text]  
• Schaefer, C. J, Lawrence, W D., Wooley, P. H (1999). Influence of long term silicone implantation on type II collagen induced arthritis in mice. Ann Rheum Dis 58: 503-509 [Abstract] [Full Text]  
• Vogel, H. (1999). Pathologic findings in nerve and muscle biopsies from 47 women with silicone breast implants. Neurology 53: 293-293 [Abstract] [Full Text]  
• Brewer, T., Colditz, G. A. (1999). Postmarketing Surveillance and Adverse Drug Reactions: Current Perspectives and Future Needs. JAMA 281: 824-829 [Abstract] [Full Text]  
• Brent, J. (1998). Silicone Breast Implants and Human Rheumatic Disease is there a Connection?. International Journal of Toxicology 17: 433-447 [Abstract]  
• Lamm, S. H. (1998). Silicone Breast Implants, Breast Cancer and Specific Connective Tissue Diseases: A Systematic Review of the Data in the Epidemiological Literature. International Journal of Toxicology 17: 497-527 [Abstract]  
• Coope, C., Dennison, E. (1998). Do silicone breast implants cause connective tissue disease?. BMJ 316: 403-404 [Full Text]  
• Nyrén, O., Yin, L., Josefsson, S., McLaughlin, J. K, Blot, W. J, Engqvist, M., Hakelius, L., Jr, J. D B., Adami, H.-O. (1998). Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ 316: 417-422 [Abstract] [Full Text]  
• Rosenbaum, J. T. (1997). Lessons from Litigation over Silicone Breast Implants: A Call for Activism by Scientists. Science 276: 1524-1525 [Abstract] [Full Text]  
• Cook, L. S., Daling, J. R., Voigt, L. F., deHart, M. P., Malone, K. E., Stanford, J. L., Weiss, N. S., Brinton, L. A., Gammon, M. D., Brogan, D. (1997). Characteristics of Women With and Without Breast Augmentation. JAMA 277: 1612-1617 [Abstract]  
• del Junco, D. J. (1997). More Breast Implant Prose and Cons: Contractures and Confounding: The Controversy Continues. JAMA 277: 1643-1644 [Abstract]  
• Gabriel, S. E., Woods, J. E., O'Fallon, W. M., Beard, C. M., Kurland, L. T., Melton, L. J. (1997). Complications Leading to Surgery after Breast Implantation. NEJM 336: 677-682 [Abstract] [Full Text]  
• Mathes, S. J. (1997). Breast Implantation -- The Quest for Safety and Quality. NEJM 336: 718-719 [Full Text]  
• Goldberg, E. P., Egilman, D. S., Stubbs, C., Barthel, H. R., Barraza, O., Meier, L. G., Sunshine, J., Greenwald, M. S., Angell, M. (1996). Evaluating the Health Risks of Breast Implants. NEJM 335: 1154-1156 [Full Text]  
• Hennekens, C. H., Lee, I-M., Cook, N. R., Hebert, P. R., Karlson, E. W., LaMotte, F., Manson, J. E., Buring, J. E. (1996). Breast Implants and Connective-Tissue Disease-Reply. JAMA 276: 103-103 [Abstract]  
• Whitmore, S. E. (1996). Breast Implants and Connective-Tissue Disease. JAMA 276: 102-102 [Abstract]  
• Litvak, J. (1996). Breast Implants and Connective-Tissue Disease. JAMA 276: 102-103 [Abstract]  
• Angell, M. (1996). Evaluating the Health Risks of Breast Implants: The Interplay of Medical Science, the Law, and Public Opinion. NEJM 334: 1513-1518 [Full Text]  
• Hennekens, C. H., Lee, I-M., Cook, N. R., Hebert, P. R., Karlson, E. W., LaMotte, F., Manson, J. E., Buring, J. E. (1996). Self-reported Breast Implants and Connective-Tissue Diseases in Female Health Professionals: A Retrospective Cohort Study. JAMA 275: 616-621 [Abstract]  
• Vasey, F. B., Aziz, N., Abraham, J. L., van Vollenhoven, R., Liang, M. H., Karlson, E. W., Sanchez-Guerrero, J. (1995). Breast Implants and Connective-Tissue Diseases. NEJM 333: 1423-1424 [Full Text]  
• Fuchs, H., Johnson, J. S., Sergent, J. S. (1995). Still More on Breast Implants and Connective-Tissue Diseases. NEJM 333: 526-526 [Full Text]  
• (1995). No Link Found between Silicone Implants and Connective-Tissue Disease. Journal Watch Dermatology 1995: 17-17 [Full Text]  
• (1995). MORE ON SILICONE IMPLANTS AND CONNECTIVE TISSUE DISEASE. JWatch General 1995: 5-5 [Full Text]